Did you know that 95% of 7,000 diseases worldwide have no treatment at all? Could the use of AI in the field of medicine be what the human race has been waiting for? In this conversation, Micheline Nader interviews Soujanya Bhumkar, co-founder of GEn1E Life Sciences alongside Dr. Ritu Lal, discussing the innovative approaches of the company in drug development - particularly the integration of AI technology. They explore the significance of data quality, the efficiency of the drug developm...